FI970298A - DHA:n käyttö farmaseuttisena koostumuksena - Google Patents
DHA:n käyttö farmaseuttisena koostumuksena Download PDFInfo
- Publication number
- FI970298A FI970298A FI970298A FI970298A FI970298A FI 970298 A FI970298 A FI 970298A FI 970298 A FI970298 A FI 970298A FI 970298 A FI970298 A FI 970298A FI 970298 A FI970298 A FI 970298A
- Authority
- FI
- Finland
- Prior art keywords
- pct
- dha
- pharmaceutical composition
- sec
- fatty acids
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Fats And Perfumes (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9510636.5A GB9510636D0 (en) | 1995-05-25 | 1995-05-25 | Fatty acid treatment |
PCT/GB1996/001265 WO1996037200A1 (en) | 1995-05-25 | 1996-05-24 | Use of dha as a pharmaceutical composition |
Publications (2)
Publication Number | Publication Date |
---|---|
FI970298A0 FI970298A0 (fi) | 1997-01-24 |
FI970298A true FI970298A (fi) | 1997-01-24 |
Family
ID=10775045
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI970298A FI970298A (fi) | 1995-05-25 | 1997-01-24 | DHA:n käyttö farmaseuttisena koostumuksena |
Country Status (17)
Country | Link |
---|---|
US (1) | US6150411A (fi) |
EP (1) | EP0774962B1 (fi) |
JP (1) | JPH10503531A (fi) |
KR (1) | KR970704433A (fi) |
AT (1) | ATE264676T1 (fi) |
AU (1) | AU722474B2 (fi) |
CA (1) | CA2195979A1 (fi) |
DE (1) | DE69632236T2 (fi) |
DK (1) | DK0774962T3 (fi) |
ES (1) | ES2217317T3 (fi) |
FI (1) | FI970298A (fi) |
GB (1) | GB9510636D0 (fi) |
HK (1) | HK1012575A1 (fi) |
NO (1) | NO970317L (fi) |
PT (1) | PT774962E (fi) |
WO (1) | WO1996037200A1 (fi) |
ZA (1) | ZA964215B (fi) |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU775421B2 (en) * | 1998-10-15 | 2004-07-29 | Dsm Ip Assets B.V. | Pufa supplements |
KR100341109B1 (ko) * | 1999-03-10 | 2002-06-20 | 이인수 | 인식력 및 기억력 증강용 식이 조성물 |
US7112609B2 (en) * | 1999-06-01 | 2006-09-26 | Drugtech Corporation | Nutritional supplements |
US6258846B1 (en) * | 1999-06-01 | 2001-07-10 | Drugtech Corporation | Nutritional supplements |
GB9918023D0 (en) | 1999-07-30 | 1999-09-29 | Unilever Plc | Skin care composition |
US6479545B1 (en) | 1999-09-30 | 2002-11-12 | Drugtech Corporation | Formulation for menopausal women |
GB9923738D0 (en) * | 1999-10-07 | 1999-12-08 | Nestle Sa | Nutritional composition |
DK1417211T3 (da) | 2001-07-27 | 2007-10-08 | Neptune Technologies & Bioress | Naturlige phospholipider af marin oprindelse, der indeholder flavonoider og polyumættede phospholipider, og deres anvendelse |
US8052992B2 (en) | 2003-10-22 | 2011-11-08 | Enzymotec Ltd. | Glycerophospholipids containing omega-3 and omega-6 fatty acids and their use in the treatment and improvement of cognitive functions |
US20050130937A1 (en) | 2003-10-22 | 2005-06-16 | Enzymotec Ltd. | Lipids containing omega-3 and omega-6 fatty acids |
US7935365B2 (en) | 2003-10-22 | 2011-05-03 | Enzymotec, Ltd. | Glycerophospholipids for the improvement of cognitive functions |
TWI365716B (en) * | 2003-12-02 | 2012-06-11 | Suntory Holdings Ltd | Oil or fat and oil compositions containing phospholipids and a long-chain polyunsaturated fatty acid supply compound, and food using same |
JP2007524674A (ja) * | 2004-01-19 | 2007-08-30 | マーテック・バイオサイエンシーズ・コーポレーション | リーリン欠損症または機能障害およびそれに関連する方法 |
US8263137B2 (en) | 2005-08-04 | 2012-09-11 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US7901710B2 (en) | 2005-08-04 | 2011-03-08 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US8202546B2 (en) | 2005-08-04 | 2012-06-19 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for use under physiologically stressful conditions |
US7998500B2 (en) | 2005-08-04 | 2011-08-16 | Vertical Pharmaceuticals, Inc. | Nutritional supplement for women |
US20070166411A1 (en) * | 2005-12-16 | 2007-07-19 | Bristol-Myers Squibb Company | Nutritional supplement containing long-chain polyunsaturated fatty acids |
US8343753B2 (en) * | 2007-11-01 | 2013-01-01 | Wake Forest University School Of Medicine | Compositions, methods, and kits for polyunsaturated fatty acids from microalgae |
GB0813599D0 (en) * | 2008-07-24 | 2008-09-03 | Pharma Marine As | Method |
KR101788342B1 (ko) | 2009-10-29 | 2017-10-19 | 아카스티 파마, 인크. | 농축된 치료용 인지질 조성물 |
US8952000B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
US8951514B2 (en) | 2011-02-16 | 2015-02-10 | Pivotal Therapeutics Inc. | Statin and omega 3 fatty acids for reduction of apolipoprotein-B levels |
US8715648B2 (en) | 2011-02-16 | 2014-05-06 | Pivotal Therapeutics Inc. | Method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (CVD) and diabetics |
US9119826B2 (en) | 2011-02-16 | 2015-09-01 | Pivotal Therapeutics, Inc. | Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (CVD) who are deficient in blood EPA and DHA levels |
US9233114B2 (en) | 2013-12-05 | 2016-01-12 | Buriva, LLC | Dietary supplement containing phospholipid-DHA derived from eggs |
US9610302B2 (en) | 2013-12-05 | 2017-04-04 | Buriva, LLC. | Composition containing phospholipid-DHA and B vitamins |
US9216199B2 (en) | 2013-12-05 | 2015-12-22 | Buriva, LLC | Nutritional supplement containing phospholipid-DHA derived from eggs |
US9549937B2 (en) | 2013-12-05 | 2017-01-24 | Burvia, LLC. | Composition containing phospholipid-DHA and folate |
WO2017207124A1 (en) * | 2016-06-01 | 2017-12-07 | Nestec S.A. | Composition for use in the prophylaxis of allergic disease |
EP4440564A1 (en) * | 2021-12-02 | 2024-10-09 | The Regents of the University of California | Compositions and methods for inhibiting seizures |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9224809D0 (en) * | 1992-11-26 | 1993-01-13 | Scotia Holdings Plc | Schizophrenia |
EP0711503A3 (en) * | 1994-11-14 | 1997-11-26 | Scotia Holdings Plc | Milk fortified with GLA and/or DGLA |
-
1995
- 1995-05-25 GB GBGB9510636.5A patent/GB9510636D0/en active Pending
-
1996
- 1996-05-24 JP JP8535515A patent/JPH10503531A/ja not_active Ceased
- 1996-05-24 DE DE69632236T patent/DE69632236T2/de not_active Expired - Fee Related
- 1996-05-24 PT PT96919911T patent/PT774962E/pt unknown
- 1996-05-24 US US08/776,250 patent/US6150411A/en not_active Expired - Lifetime
- 1996-05-24 AT AT96919911T patent/ATE264676T1/de not_active IP Right Cessation
- 1996-05-24 EP EP96919911A patent/EP0774962B1/en not_active Expired - Lifetime
- 1996-05-24 WO PCT/GB1996/001265 patent/WO1996037200A1/en active IP Right Grant
- 1996-05-24 AU AU58277/96A patent/AU722474B2/en not_active Ceased
- 1996-05-24 DK DK96919911T patent/DK0774962T3/da active
- 1996-05-24 ZA ZA964215A patent/ZA964215B/xx unknown
- 1996-05-24 ES ES96919911T patent/ES2217317T3/es not_active Expired - Lifetime
- 1996-05-24 CA CA002195979A patent/CA2195979A1/en not_active Abandoned
- 1996-05-24 KR KR1019970700488A patent/KR970704433A/ko active IP Right Grant
-
1997
- 1997-01-24 FI FI970298A patent/FI970298A/fi unknown
- 1997-01-24 NO NO970317A patent/NO970317L/no not_active Application Discontinuation
-
1998
- 1998-12-18 HK HK98113985A patent/HK1012575A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO970317D0 (no) | 1997-01-24 |
ATE264676T1 (de) | 2004-05-15 |
HK1012575A1 (en) | 1999-08-06 |
NO970317L (no) | 1997-01-24 |
EP0774962A1 (en) | 1997-05-28 |
ZA964215B (en) | 1996-12-04 |
FI970298A0 (fi) | 1997-01-24 |
PT774962E (pt) | 2004-09-30 |
KR970704433A (ko) | 1997-09-06 |
AU5827796A (en) | 1996-12-11 |
ES2217317T3 (es) | 2004-11-01 |
GB9510636D0 (en) | 1995-07-19 |
WO1996037200A1 (en) | 1996-11-28 |
EP0774962B1 (en) | 2004-04-21 |
DE69632236T2 (de) | 2005-04-14 |
JPH10503531A (ja) | 1998-03-31 |
DE69632236D1 (de) | 2004-05-27 |
AU722474B2 (en) | 2000-08-03 |
CA2195979A1 (en) | 1996-11-28 |
DK0774962T3 (da) | 2004-08-09 |
US6150411A (en) | 2000-11-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI970298A0 (fi) | DHA:n käyttö farmaseuttisena koostumuksena | |
GB9220667D0 (en) | Improvements in or relating to dioic acids | |
ID21473A (id) | Sediaan farmasi yang mengandung asam eikosapentanoat dan asam stearidonat | |
ATE216230T1 (de) | Essentielle fettsäuren zur vorbeugung von kardiovaskulären anfällen | |
DE68905863D1 (de) | Zusammensetzungen essentieller fettsaeuren. | |
DE69409969D1 (de) | Salze der mehrfach ungesättigten fettsäuren und diese enthaltende pharmazeutischen zusammensetzungen | |
NZ292121A (en) | 5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalene-2-yl derivatives and pharmaceutical compositions thereof | |
BG102011A (en) | 1,3-propane diol derivatives as bioactive compounds(21) 102012 (22) 31.10.97 (13) l (19) bg (41) 29.05.98 (51) 6c 07 d 209/28 a (51) 6c 07 d 339/04 b (51) 6a 61 k 31/23 b (51) 6c 07 c 69/587 b (51) 6c 07 c 69/767 b (86) pct/gb96/01052,01.05.96 (87) wo96/34855,07.11.96 (31) 9508823 (32) 01.05.95 (33) gb (31) 9517107 (32) 21.08.95 (33) gb (31) 9605440 (32) 15.03.96 (33) gb (71) gb scotia holdings plc (72) gb horrobin, david f. (72) gb manku, mehar (72) gb mcmordie, austin (72) gb knowles, phillip (72) gb redden, peter (72) gb pitt, andrea (74) olga ruseva sirakova, (74) 1124 sofija,kompl."javorov",bl.19,vkh.g (54) fatty acid esters as bioactive compounds | |
HK37694A (en) | Fatty acids compositions | |
DE59710177D1 (de) | Omega-3-fettsäurehaltige zubereitung aus mikroorganismen als prophylaktikum bzw. therapeutikum gegen kokzidiose bei tieren | |
KR910007858A (ko) | 초기-촉진 및 향상된 진통제로서의 s(+)-이부프로펜-l-아미노산 및 s(+)-이부프로펜-d-아미노산 | |
PT920323E (pt) | Nova utilizacao de fosfolipidos de origem animal em terapeutica e/ou dietetica | |
ATE120954T1 (de) | Verwendung von essentiellen fettsäuren zur herstellung eines arzneimittels zur behandlung von aids. | |
ATE258792T1 (de) | Diät mit hohem lipidgehalt | |
DE69415018D1 (de) | Oralanzuwendende flüssige arzneizubereitung enthaltend 2-(4-isobutylphenyl)propionsäure | |
NZ306510A (en) | Niacin derivatives which include a fatty acid or fatty acid alcohol residue and their use in medicaments and skin care compositions | |
ES2124395T3 (es) | Utilizacion de esteres de diglicerina contra las impurezas de la piel. | |
SG77567A1 (en) | Anti-bloom triglyceride compositions | |
DK0613367T3 (da) | Dermatologiske og kosmetiske præparater | |
ATE175344T1 (de) | Gelbildende präparate, die optisch angereicherte gelbildner enthalten | |
ATE63684T1 (de) | Deodorant. | |
EA200100662A1 (ru) | Способ и композиция для поддержания и восстановления целостности кишки | |
DK0599967T3 (da) | Opspaltning af arylalkansyrer. | |
DK0741579T3 (da) | Vandig formulering med forhalet frigivelse | |
HUP0000419A2 (hu) | Eikozapentaénsavat és/vagy sztearidonsavat tartalmazó gyógyászati készítmény |